Axonics Modulation Technologies Stock Beta
Axonics Modulation Technologies fundamentals help investors to digest information that contributes to Axonics Modulation's financial success or failures. It also enables traders to predict the movement of Axonics Stock. The fundamental analysis module provides a way to measure Axonics Modulation's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axonics Modulation stock.
Axonics |
Axonics Modulation Technologies Company Beta Analysis
Axonics Modulation's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Axonics Modulation Beta | 0.83 |
Most of Axonics Modulation's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axonics Modulation Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Axonics Modulation Technologies has a Beta of 0.827. This is 3.84% lower than that of the Health Care Equipment & Supplies sector and 20.48% lower than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Axonics Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axonics Modulation's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axonics Modulation could also be used in its relative valuation, which is a method of valuing Axonics Modulation by comparing valuation metrics of similar companies.Axonics Modulation is currently under evaluation in beta category among its peers.
As returns on the market increase, Axonics Modulation's returns are expected to increase less than the market. However, during the bear market, the loss of holding Axonics Modulation is expected to be smaller as well.
Axonics Fundamentals
| Return On Equity | -0.0089 | |||
| Return On Asset | -0.0063 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 3.32 B | |||
| Shares Outstanding | 51.11 M | |||
| Shares Owned By Insiders | 1.26 % | |||
| Shares Owned By Institutions | 87.22 % | |||
| Number Of Shares Shorted | 3.31 M | |||
| Price To Earning | (10.68) X | |||
| Price To Book | 5.46 X | |||
| Price To Sales | 8.40 X | |||
| Revenue | 366.38 M | |||
| Gross Profit | 197.66 M | |||
| EBITDA | 7.78 M | |||
| Net Income | (6.09 M) | |||
| Cash And Equivalents | 213.23 M | |||
| Cash Per Share | 4.53 X | |||
| Total Debt | 27.62 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 10.49 X | |||
| Book Value Per Share | 13.00 X | |||
| Cash Flow From Operations | (2.02 M) | |||
| Short Ratio | 7.14 X | |||
| Earnings Per Share | (0.10) X | |||
| Price To Earnings To Growth | (0.56) X | |||
| Target Price | 72.0 | |||
| Number Of Employees | 797 | |||
| Beta | 0.83 | |||
| Market Capitalization | 3.63 B | |||
| Total Asset | 719.92 M | |||
| Retained Earnings | (380.35 M) | |||
| Working Capital | 445.61 M | |||
| Current Asset | 171.14 M | |||
| Current Liabilities | 12.98 M | |||
| Net Asset | 719.92 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Axonics Stock
If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |